Jeremiah Hadwen Selected Research

Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)

1/2014

VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremiah Hadwen Research Topics

Disease

3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2014 - 08/2011
2	Rare Diseases (Rare Disease) 06/2021 - 03/2019
1	Fistula 04/2022
1	Transverse Myelitis (Necrotizing Myelitis) 04/2022
1	Infarction (Infarctions) 04/2022
1	Spinal Cord Diseases 04/2022
1	Muscular Dystrophies (Muscular Dystrophy) 06/2021
1	Stroke (Strokes) 01/2021
1	Insulin Resistance 01/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Myotonic Dystrophy (Dystrophia Myotonica) 08/2015
1	Infant Death 01/2014
1	Muscular Atrophy (Muscle Atrophy) 09/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2019 - 09/2013
2	Pharmaceutical PreparationsIBA 06/2021 - 01/2018
1	SteroidsIBA 04/2022
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Biological ProductsIBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 06/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 03/2019
1	Thyroid HormonesIBA 01/2018
1	UtrophinIBA 01/2018
1	AnisomycinIBA 01/2018
1	DystrophinIBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 08/2015
1	Protein Kinases (Protein Kinase)IBA 08/2015
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 01/2014
1	Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)IBA 01/2014
1	Celecoxib (Celebrex)FDA Link 09/2013
1	ProlactinIBA 08/2011

Therapy/Procedure

1	Therapeutics 03/2019